The worldwide healthcare sector is witnessing an unprecedented focus on neurodegenerative disorders, with Alzheimer's disease emerging as a primary area of concern for medical professionals, pharmaceutical companies, and policymakers alike. This progressive neurological condition affects millions globally, creating both significant healthcare challenges and substantial market...